Lv4
440 积分 2024-02-18 加入
Evolution and Emergence of Therapeutic Monoclonal Antibodies
1个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
1个月前
已完结
CRESS: improving the assessment of disease activity in Sjögren's syndrome
6个月前
已完结
Novel therapies in Sjögren’s disease: A systematic review of the literature
6个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
7个月前
已完结
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma
8个月前
已完结
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
11个月前
已完结
Current indications for surgery in patients with lung cancer after neoadjuvant targeted therapy: a systematic review
11个月前
已完结
P3.18.59 Resistance Mechanisms and Sequential Therapies Following 1St Line Lorlatinib in ALK+ NSCLC: A Real-World Study (LORES CTONG2501)
11个月前
已完结
First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma
1年前
已完结
皖公网安备34019202002308
